5 Prime Sciences, a biotechnology data analytics company focused on using human genetics to accelerate drug development, has entered a strategic collaboration with Eli Lilly and Company dedicated to accelerating target discovery and early development in the field of cardio-metabolic diseases.   This collaboration integrates Lilly’s leadership in cardio-metabolic disease therapies with 5 Prime Sciences’ expertise in discovery and validation of drug targets using human genetics, prot...